X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE ALEMBIC LTD TTK HEALTHCARE/
ALEMBIC LTD
 
P/E (TTM) x 19.2 53.4 36.0% View Chart
P/BV x 2.3 2.2 104.0% View Chart
Dividend Yield % 0.7 0.5 157.1%  

Financials

 TTK HEALTHCARE   ALEMBIC LTD
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-18
ALEMBIC LTD
Mar-18
TTK HEALTHCARE/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs1,45872 2,024.6%   
Low Rs79534 2,345.4%   
Sales per share (Unadj.) Rs408.74.7 8,695.5%  
Earnings per share (Unadj.) Rs12.96.1 210.7%  
Cash flow per share (Unadj.) Rs23.66.2 378.6%  
Dividends per share (Unadj.) Rs5.000.20 2,500.0%  
Dividend yield (eoy) %0.40.4 117.5%  
Book value per share (Unadj.) Rs164.940.7 405.5%  
Shares outstanding (eoy) m14.13267.03 5.3%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.811.3 24.5%   
Avg P/E ratio x87.68.7 1,009.7%  
P/CF ratio (eoy) x47.68.5 561.9%  
Price / Book Value ratio x6.81.3 524.6%  
Dividend payout %38.93.3 1,186.6%   
Avg Mkt Cap Rs m15,91614,139 112.6%   
No. of employees `0002.2NA-   
Total wages/salary Rs m1,090207 525.5%   
Avg. sales/employee Rs Th2,573.8NM-  
Avg. wages/employee Rs Th485.7NM-  
Avg. net profit/employee Rs Th81.0NM-  
INCOME DATA
Net Sales Rs m5,7761,255 460.1%  
Other income Rs m76370 20.4%   
Total revenues Rs m5,8511,625 360.0%   
Gross profit Rs m426111 383.0%  
Depreciation Rs m15238 403.2%   
Interest Rs m472 2,782.4%   
Profit before tax Rs m302442 68.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12024 500.2%   
Profit after tax Rs m1821,630 11.1%  
Gross profit margin %7.48.9 83.2%  
Effective tax rate %39.75.4 733.0%   
Net profit margin %3.1129.8 2.4%  
BALANCE SHEET DATA
Current assets Rs m2,5561,867 136.9%   
Current liabilities Rs m1,675591 283.4%   
Net working cap to sales %15.3101.6 15.0%  
Current ratio x1.53.2 48.3%  
Inventory Days Days3394 35.5%  
Debtors Days Days3574 47.6%  
Net fixed assets Rs m1,1031,791 61.6%   
Share capital Rs m141534 26.5%   
"Free" reserves Rs m2,18810,324 21.2%   
Net worth Rs m2,33010,858 21.5%   
Long term debt Rs m741 16.0%   
Total assets Rs m4,07311,591 35.1%  
Interest coverage x7.4260.9 2.8%   
Debt to equity ratio x00 74.7%  
Sales to assets ratio x1.40.1 1,309.4%   
Return on assets %5.614.1 39.9%  
Return on equity %7.815.0 52.0%  
Return on capital %14.915.2 98.3%  
Exports to sales %3.01.5 192.7%   
Imports to sales %0.621.0 2.9%   
Exports (fob) Rs m17219 886.6%   
Imports (cif) Rs m35263 13.2%   
Fx inflow Rs m17219 886.6%   
Fx outflow Rs m55264 20.9%   
Net fx Rs m117-244 -47.8%   
CASH FLOW
From Operations Rs m253236 107.3%  
From Investments Rs m-226-224 100.7%  
From Financial Activity Rs m-72-27 270.7%  
Net Cashflow Rs m-41-15 278.4%  

Share Holding

Indian Promoters % 65.4 64.0 102.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 0.2 1,850.0%  
FIIs % 5.2 9.7 53.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 26.1 98.9%  
Shareholders   12,723 54,701 23.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   J.B.CHEMICALS  VENUS REMEDIES  STERLING BIOTECH  ELDER PHARMA  AUROBINDO PHARMA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Marginally Lower; Banking and Automobile Stocks Witness Selling(Closing)

After opening the day on a strong note, Indian share markets witnessed selling pressure during closing hours and ended their trading session marginally lower.

Related Views on News

TTK HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

More Views on News

Most Popular

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

A Simple 3-Point Investing Manifesto for You the Indian Investor(The 5 Minute Wrapup)

Apr 11, 2019

A must have checklist for every investor in the Indian stock market.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Apr 23, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS